Piscataqua Savings Bank’s Finch Therapeutics Group, Inc. Common Stock FNCH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-13
Closed -$5K 357
2021
Q3
$5K Hold
13
﹤0.01% 303
2021
Q2
$6K Hold
13
0.01% 290
2021
Q1
$6K Buy
+13
New +$6.62K 0.01% 287

Other funds holding FNCH

Piscataqua Savings Bank's FNCH Position: Q4 2021 in Review

Piscataqua Savings Bank sold out of Finch Therapeutics Group, Inc. Common Stock (FNCH) in Q4 2021, closing a stake of 13 shares — an estimated $5K sold.

Piscataqua Savings Bank first reported a position in FNCH in Q1 2021 and held it in 3 quarters. The position peaked at $6K in Q2 2021. 51 funds tracked by Wall St. Rank hold FNCH as of Q4 2021.

  • Piscataqua Savings Bank reported no remaining Finch Therapeutics Group, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Piscataqua Savings Bank sold 13 Finch Therapeutics Group, Inc. Common Stock shares in Q4 2021, an estimated $5K.
  • Piscataqua Savings Bank first reported a position in Finch Therapeutics Group, Inc. Common Stock in Q1 2021 and held it in 3 quarters.
  • Piscataqua Savings Bank's Finch Therapeutics Group, Inc. Common Stock position peaked at $6K in Q2 2021.
  • 51 funds tracked by Wall St. Rank held Finch Therapeutics Group, Inc. Common Stock as of Q4 2021.

Based on Piscataqua Savings Bank's 13F filing for Q4 2021, filed 14 Jan 2022.